US 11357770
Method of treating immunoglobulin light chain amyloidosis
granted A61KA61K31/47A61K31/4709
Quick answer
US patent 11357770 (Method of treating immunoglobulin light chain amyloidosis) held by Alterity Therapeutics Limited expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alterity Therapeutics Limited
- Grant date
- Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/47, A61K31/4709, A61P, A61P39/04